Pathological characteristics and immune microenvironment of SMARCA4-deficient undifferentiated uterine sarcoma

Jie Gao1, Ruirui Fan2, Dahong Chen3

  • 1Department of Pathology, Xiamen Humanity Hospital Fujian Medical University, No.3777 Xianyue Street, Xiamen, Fujian, 361000, China.

Insights

SMARCA4-deficient undifferentiated uterine sarcoma (SDUS) is a rare cancer. This case study analyzes its immune microenvironment, revealing CD8/CD68/PD-1/PD-L1 expression, which may aid future diagnosis and treatment strategies.

Area of Science:

  • Gynecologic Pathology
  • Oncology
  • Immunology

Background:

  • SMARCA4-deficient undifferentiated uterine sarcoma (SDUS) is a rare, highly invasive malignancy with poor prognosis and no current standard treatment.
  • Research on the immune microenvironment of SDUS is limited globally.
  • Understanding the immune landscape is crucial for developing targeted therapies.

Purpose of the Study:

  • To report a case of SDUS with detailed diagnostic analysis.
  • To investigate the immune microenvironment of SDUS.
  • To enhance diagnostic awareness and potentially inform future therapeutic approaches.

Main Methods:

  • Morphological and immunohistochemical analysis of tumor tissue.
  • Molecular detection techniques.
  • Immune microenvironment assessment using immunohistochemistry and multiple immunofluorescence staining.

Main Results:

  • Tumor cells exhibited retained INI-1, focal CD10, and lost BRG1, CK-pan, synaptophysin, desmin, and ER expression.
  • CD3 and CD8 positive immune cells infiltrated the tumor, with no PD-L1 detected initially.
  • Multiple immunofluorescence revealed co-expression of CD8/CD68/PD-1/PD-L1 on immune and tumor cells.

Conclusions:

  • This case report provides insights into the diagnostic features of SDUS.
  • The identified immune microenvironment characteristics, including PD-1/PD-L1 expression, offer potential therapeutic targets.
  • Further research into the SDUS immune landscape is warranted to improve patient outcomes.